Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 123

Publication Record

Connections

Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis.
Menshikh A, Scarfe L, Delgado R, Finney C, Zhu Y, Yang H, de Caestecker MP
(2019) Am J Physiol Renal Physiol 317: F1383-F1397
MeSH Terms: Acute Kidney Injury, Animals, Antineoplastic Agents, Cisplatin, Fibrosis, Kidney, Male, Mice, Microvascular Rarefaction, Renal Insufficiency, Chronic, Reperfusion Injury, Rhabdomyolysis
Added May 10, 2020
0 Communities
1 Members
0 Resources
MeSH Terms
Clinical and Genome-wide Analysis of Cisplatin-induced Tinnitus Implicates Novel Ototoxic Mechanisms.
El Charif O, Mapes B, Trendowski MR, Wheeler HE, Wing C, Dinh PC, Frisina RD, Feldman DR, Hamilton RJ, Vaughn DJ, Fung C, Kollmannsberger C, Mushiroda T, Kubo M, Gamazon ER, Cox NJ, Huddart R, Ardeshir-Rouhani-Fard S, Monahan P, Fossa SD, Einhorn LH, Travis LB, Dolan ME
(2019) Clin Cancer Res 25: 4104-4116
MeSH Terms: Adult, Aged, Antineoplastic Agents, Case-Control Studies, Cell Line, Tumor, Cell Survival, Cisplatin, Disease Susceptibility, Genetic Predisposition to Disease, Genome-Wide Association Study, Humans, Middle Aged, Ototoxicity, Polymorphism, Single Nucleotide, Risk Factors, Self Report, Tinnitus, Young Adult
Added July 17, 2019
0 Communities
1 Members
0 Resources
18 MeSH Terms
CRISPR/Cas9 engineering of a KIM-1 reporter human proximal tubule cell line.
Veach RA, Wilson MH
(2018) PLoS One 13: e0204487
MeSH Terms: Acute Kidney Injury, CRISPR-Cas Systems, Cell Line, Cisplatin, Gene Knock-In Techniques, Gene Targeting, Genes, Reporter, Genetic Engineering, Glucose, Green Fluorescent Proteins, Hepatitis A Virus Cellular Receptor 1, Homologous Recombination, Humans, Kidney Tubules, Proximal, Luciferases, Up-Regulation
Added December 13, 2018
0 Communities
1 Members
0 Resources
16 MeSH Terms
Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer.
Dolan ME, El Charif O, Wheeler HE, Gamazon ER, Ardeshir-Rouhani-Fard S, Monahan P, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Fung C, Kim J, Fossa SD, Hertz DL, Mushiroda T, Kubo M, Einhorn LH, Cox NJ, Travis LB, Platinum Study Group
(2017) Clin Cancer Res 23: 5757-5768
MeSH Terms: Adolescent, Adult, Age Factors, Age of Onset, Aged, Cancer Survivors, Cell Cycle Proteins, Cisplatin, Gene Expression Regulation, Neoplastic, Genome-Wide Association Study, Genotype, Humans, Hypertension, Male, Middle Aged, Neoplasm Proteins, Peripheral Nervous System Diseases, Polymorphism, Single Nucleotide, Risk Factors, Testicular Neoplasms
Added October 27, 2017
0 Communities
1 Members
0 Resources
20 MeSH Terms
IGFBP3 Modulates Lung Tumorigenesis and Cell Growth through IGF1 Signaling.
Wang YA, Sun Y, Palmer J, Solomides C, Huang LC, Shyr Y, Dicker AP, Lu B
(2017) Mol Cancer Res 15: 896-904
MeSH Terms: Animals, Apoptosis, Biomarkers, Tumor, Carcinogenesis, Carcinoma, Non-Small-Cell Lung, Cell Line, Tumor, Cell Proliferation, Cisplatin, Drug Resistance, Neoplasm, Gene Expression Regulation, Neoplastic, Humans, Insulin-Like Growth Factor Binding Protein 3, Insulin-Like Growth Factor I, Mice, Mice, Knockout, Proto-Oncogene Proteins p21(ras)
Added April 18, 2017
0 Communities
1 Members
0 Resources
16 MeSH Terms
A Randomized Phase II Neoadjuvant Study of Cisplatin, Paclitaxel With or Without Everolimus in Patients with Stage II/III Triple-Negative Breast Cancer (TNBC): Responses and Long-term Outcome Correlated with Increased Frequency of DNA Damage Response Gene Mutations, TNBC Subtype, AR Status, and Ki67.
Jovanović B, Mayer IA, Mayer EL, Abramson VG, Bardia A, Sanders ME, Kuba MG, Estrada MV, Beeler JS, Shaver TM, Johnson KC, Sanchez V, Rosenbluth JM, Dillon PM, Forero-Torres A, Chang JC, Meszoely IM, Grau AM, Lehmann BD, Shyr Y, Sheng Q, Chen SC, Arteaga CL, Pietenpol JA
(2017) Clin Cancer Res 23: 4035-4045
MeSH Terms: Adult, Cisplatin, DNA Damage, Drug-Related Side Effects and Adverse Reactions, Everolimus, Female, High-Throughput Nucleotide Sequencing, Humans, Ki-67 Antigen, Lymphocytes, Tumor-Infiltrating, Middle Aged, Mutation, Neoplasm Staging, Paclitaxel, Receptors, Androgen, Treatment Outcome, Triple Negative Breast Neoplasms
Added April 9, 2017
1 Communities
2 Members
0 Resources
17 MeSH Terms
Current Management of Refractory Germ Cell Tumors and Future Directions.
Allen JC, Kirschner A, Scarpato KR, Morgans AK
(2017) Curr Oncol Rep 19: 8
MeSH Terms: Antineoplastic Combined Chemotherapy Protocols, Cisplatin, Disease Management, Hematopoietic Stem Cell Transplantation, Humans, Male, Neoplasms, Germ Cell and Embryonal
Added April 2, 2019
0 Communities
1 Members
0 Resources
MeSH Terms
Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial.
Liang J, Bi N, Wu S, Chen M, Lv C, Zhao L, Shi A, Jiang W, Xu Y, Zhou Z, Wang W, Chen D, Hui Z, Lv J, Zhang H, Feng Q, Xiao Z, Wang X, Liu L, Zhang T, Du L, Chen W, Shyr Y, Yin W, Li J, He J, Wang L
(2017) Ann Oncol 28: 777-783
MeSH Terms: Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Carboplatin, Carcinoma, Non-Small-Cell Lung, Chemoradiotherapy, Cisplatin, Etoposide, Female, Humans, Kaplan-Meier Estimate, Lung Neoplasms, Male, Middle Aged, Neoplasm Staging, Paclitaxel, Proportional Hazards Models
Added April 18, 2017
0 Communities
1 Members
0 Resources
17 MeSH Terms
Integrated, High-Throughput, Multiomics Platform Enables Data-Driven Construction of Cellular Responses and Reveals Global Drug Mechanisms of Action.
Norris JL, Farrow MA, Gutierrez DB, Palmer LD, Muszynski N, Sherrod SD, Pino JC, Allen JL, Spraggins JM, Lubbock AL, Jordan A, Burns W, Poland JC, Romer C, Manier ML, Nei YW, Prentice BM, Rose KL, Hill S, Van de Plas R, Tsui T, Braman NM, Keller MR, Rutherford SA, Lobdell N, Lopez CF, Lacy DB, McLean JA, Wikswo JP, Skaar EP, Caprioli RM
(2017) J Proteome Res 16: 1364-1375
MeSH Terms: Apoptosis, Cell Line, Cell Survival, Cells, Cisplatin, Computational Biology, High-Throughput Screening Assays, Humans, Metabolic Networks and Pathways
Added March 10, 2017
2 Communities
8 Members
0 Resources
9 MeSH Terms
Variants in and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.
Wheeler HE, Gamazon ER, Frisina RD, Perez-Cervantes C, El Charif O, Mapes B, Fossa SD, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Fung C, Kollmannsberger C, Kim J, Mushiroda T, Kubo M, Ardeshir-Rouhani-Fard S, Einhorn LH, Cox NJ, Dolan ME, Travis LB
(2017) Clin Cancer Res 23: 3325-3333
MeSH Terms: Antineoplastic Agents, Cisplatin, Female, Genome-Wide Association Study, Genotype, Hearing Loss, Humans, Male, Membrane Proteins, Polymorphism, Single Nucleotide, Testicular Neoplasms
Added April 13, 2017
0 Communities
1 Members
0 Resources
11 MeSH Terms